首页> 美国卫生研究院文献>Scientific Reports >Biological ingredient analysis of traditional Chinese medicine preparation based on high-throughput sequencing: the story for Liuwei Dihuang Wan
【2h】

Biological ingredient analysis of traditional Chinese medicine preparation based on high-throughput sequencing: the story for Liuwei Dihuang Wan

机译:基于高通量测序的中药制剂生物成分分析:六味地黄丸的故事

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although Traditional Chinese Medicine (TCM) preparations have long history with successful applications, the scientific and systematic quality assessment of TCM preparations mainly focuses on chemical constituents and is far from comprehensive. There are currently only few primitive studies on assessment of biological ingredients in TCM preparations. Here, we have proposed a method, M-TCM, for biological assessment of the quality of TCM preparations based on high-throughput sequencing and metagenomic analysis. We have tested this method on Liuwei Dihuang Wan (LDW), a TCM whose ingredients have been well-defined. Our results have shown that firstly, this method could determine the biological ingredients of LDW preparations. Secondly, the quality and stability of LDW varies significantly among different manufacturers. Thirdly, the overall quality of LDW samples is significantly affected by their biological contaminations. This novel strategy has the potential to achieve comprehensive ingredient profiling of TCM preparations.
机译:尽管中药(TCM)制剂历史悠久,成功应用,但对中药制剂的科学,系统的质量评估主要集中在化学成分上,远非全面。目前,只有很少的原始研究来评估中药制剂中的生物成分。在这里,我们提出了一种基于高通量测序和宏基因组学分析的中药制剂质量生物学评估方法M-TCM。我们已经在成分明确的中药六味地黄丸(LDW)上测试了该方法。我们的结果表明,首先,该方法可以确定LDW制剂的生物学成分。其次,LDW的质量和稳定性在不同制造商之间存在很大差异。第三,LDW样品的整体质量受到其生物污染的显着影响。这种新颖的策略具有实现中药制剂成分全面分析的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号